Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cardio Flow
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cardio Flow

Cardio Flow

Pre-Seed

US-based Cardio Flow, pioneering a novel approach to orbital atherectomy.

HQ
Saint Paul, MN, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Cardio Flow, founded in Saint Paul, United States, is an early-stage development company dedicated to revolutionizing the treatment of peripheral artery disease (PAD) through its innovative approach to orbital atherectomy. The company's core mission is to improve patient outcomes by providing advanced medical devices that offer a safer and more effective method for removing arterial plaque. Cardio Flow's flagship product, the FreedomFlow platform, is designed for use by physicians and clinics to enhance the debulking process in PAD treatments.

Notable figures associated with Cardio Flow include leading medical professionals and experienced industry investors who support its mission. The company has achieved significant milestones, including successful clinical trials such as FAST I and FAST II, which have demonstrated the effectiveness of the FreedomFlow platform. Cardio Flow's impact lies in its potential to transform the standard of care for PAD patients, offering a promising alternative to existing atherectomy techniques and improving overall vascular health outcomes.

Cardio Flow - Similar Companies

Native Cardio logo

Native Cardio

nativecardio.com

Flow Medical logo

Flow Medical

flowmedical.co

CardioFocus logo

CardioFocus

cardiofocus.com

Heartflow logo

Heartflow

Reflow Medical logo

Reflow Medical

reflowmedical.com

MicroPort CardioFlow logo

MicroPort CardioFlow

ClearFlow logo

ClearFlow

clearflow.com

FastWave Medical logo

FastWave Medical

Free Flow Medical logo

Free Flow Medical

CardieX logo

CardieX

cardiex.com

CardioOptics logo

CardioOptics

International Cardio logo

International Cardio

hifu-rx.com

Traverse Vascular logo

Traverse Vascular

Starlight Cardiovascular logo

Starlight Cardiovascular

Micro Medical Solutions logo

Micro Medical Solutions

Cardio Flow - Quick Facts

Who are Cardio Flow's competitors?

Companies similar to Cardio Flow include Native Cardio, Flow Medical, CardioFocus and Heartflow.

When was Cardio Flow founded?

Cardio Flow was founded in 2014.

Where is Cardio Flow's headquarters located?

Cardio Flow's headquarters is located in Saint Paul, MN, US.

When was Cardio Flow's last funding round?

Cardio Flow's most recent funding round was for $1.2M (USD) in September 2023.

How much has Cardio Flow raised to-date?

As of Sep 11, 2023, Cardio Flow has raised a total of $17.6M (USD).

How many employees does Cardio Flow have?

Cardio Flow has 33 employees as of Feb 5, 2024.

Cardio Flow - Classification

Industry
  • Hardware
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified